![Laura G. Hansen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laura G. Hansen
Investor Relations Contact at
DENALI THERAPEUTICS INC.
Profile
Laura G.
Hansen currently works at Denali Therapeutics, Inc., as Vice President-Investor Relations from 2020.
Dr. Hansen also formerly worked at Corvas International, Inc., as Director-Corporate Communications from 2001 to 2002, Threshold Pharmaceuticals, Inc., as Senior Director-Corporate Communications, FibroGen, Inc., as Director-Corporate Communications from 2002 to 2012, Aimmune Therapeutics, Inc., as Vice President-Investor Relations from 2016 to 2019, and BlackThorn Therapeutics, Inc., as Vice President-Corporate Affairs from 2019 to 2020.
Dr. Hansen received her undergraduate degree and doctorate degree from The University of Texas at Austin.
Laura G. Hansen active positions
| Companies | Position | Start |
|---|---|---|
| DENALI THERAPEUTICS INC. | Investor Relations Contact | 2020-08-31 |
Former positions of Laura G. Hansen
| Companies | Position | End |
|---|---|---|
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for neuron developmental disorders | Corporate Officer/Principal | 2020-08-31 |
| AIMMUNE THERAPEUTICS, INC. | Investor Relations Contact | 2019-02-28 |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Investor Relations Contact | 2016-01-31 |
| KYNTRA BIO, INC. | Public Communications Contact | 2012-06-30 |
Corvas International, Inc.
 Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases | Public Communications Contact | 2002-06-30 |
Training of Laura G. Hansen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
41
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Corvas International, Inc.
Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases | Health Technology |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for neuron developmental disorders | Health Technology |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Laura G. Hansen
